Pharmabiz1h
Novartis Kisqali receives European approval in a broad population of patients with HR+/HER2- early breast cancer at high risk of recurrence
Novartis Kisqali receives European approval in a broad population of patients with HR+/HER2- early breast cancer at high risk of recurrence: Basel Thursday, November 28, 2024, 09: ...
Pharmabiz2h
PCI asks all pharmacy institutions to appoint nodal officers related to award of scholarship
PCI asks all pharmacy institutions to appoint nodal officers related to award of scholarship: Gireesh Babu, New Delhi ...
Pharmabiz2h
DGFT updates import policy for pharma in sync with Finance Act 2024
DGFT updates import policy for pharma in sync with Finance Act 2024: Shardul Nautiyal, Mumbai Thursday, November 28, 2024, 08:00 Hrs [IST] The Union ministry of commerce & industr ...
Pharmabiz2h
Indian healthcare industry turns to technology to address fragmented payment landscape
Indian healthcare industry turns to technology to address fragmented payment landscape: Nandita Vijayasimha, Bengaluru Thursday, November 28, 2024, 08:00 Hrs [IST] Indian healthca ...
Pharmabiz2h
BIS prioritises standard development for 214 critical medical devices by December 2025
BIS prioritises standard development for 214 critical medical devices by December 2025: Our Bureau, New Delhi Thursday, November 28, 2024, 08:00 Hrs [IST] The Bureau of Indian Sta ...
Pharmabiz10h
Cassava Sciences’ ReThink-ALZ phase 3 study of simufilam in mild-to-moderate AD fails to meet co-primary endpoints
Cassava Sciences, Inc., a clinical-stage biotechnology company focused on developing a novel, investigational treatment for Alzheimer’s disease (AD) dementia, announced that the topline results from ...
Pharmabiz17h
BioNxt reports expansion of its next-generation product pipeline with innovative solutions for autoimmune diseases and longevity
BioNxt reports expansion of its next-generation product pipeline with innovative solutions for autoimmune diseases and longevity: Vancouver, BC Wednesday, November 27, 2024, 17:00 ...
Pharmabiz18h
Abbott announces first step toward its software-guided balloon-expandable TAVI System to treat aortic stenosis
Abbott announces first step toward its software-guided balloon-expandable TAVI System to treat aortic stenosis: Abbott Park, Illinois Wednesday, November 27, 2024, 16:00 Hrs [IST] ...
Pharmabiz19h
J INTS BIO, MD Anderson develop ‘JIN-001' for brain tumour treatment to enhance radiation and chemotherapy efficacy
J INTS BIO, MD Anderson develop ‘JIN-001' for brain tumour treatment to enhance radiation and chemotherapy efficacy: Seoul, South Korea Wednesday, November 27, 2024, 15:00 Hrs [ ...
Pharmabiz19h
Johnson & Johnson unveils ‘India Detects to Defeat’ initiative to urge for early lung cancer detection and testing
Johnson & Johnson unveils ‘India Detects to Defeat’ initiative to urge for early lung cancer detection and testing: Our Bureau, Mumbai Wednesday, November 27, 2024, 14:45 Hrs ...
Pharmabiz19h
Centrum addresses growing joint health concerns with launch of Centrum Joint & Mobility Capsule in India
Centrum addresses growing joint health concerns with launch of Centrum Joint & Mobility Capsule in India: Our Bureau, Mumbai Wednesday, November 27, 2024, 14:30 Hrs [IST] Centrum, ...
Pharmabiz20h
Philips advances remote imaging leadership with US FDA 510(k) clearance for innovative remote scanning and protocol management capabilities
Philips advances remote imaging leadership with US FDA 510(k) clearance for innovative remote scanning and protocol management capabilities: Amsterdam, the Netherlands Wednesday, ...